Sugar Maple Asset Management »

Iovance Biotherapeutics shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $300k 110k 2.73

More positions owned by Sugar Maple Asset Management

Spdr Gold Tr Gold Shs (GLD)
Abbvie (ABBV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr TRS FLT RT BD (TFLO)
Abbott Laboratories (ABT)
Ishares Silver Tr Ishares (SLV)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
T Rowe Price Etf Cap Appreciation (TCAF)
Vaneck Etf Trust Clo Etf (CLOI)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr Series Trust State Street Spd (SDY)

View all positions for Sugar Maple Asset Management

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Invenomic Capital Management
Goldman Sachs Group
Long Focus Capital Management
Geode Capital Management
Palo Alto Investors
Susquehanna International
Citadel Advisors
Millennium Management
Hrt Financial
Jane Street
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics